Rudi Pauwels
Directeur Général chez Biocartis SA
Provenance du réseau au premier degré de Rudi Pauwels
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Biocartis SA
 Biocartis SA Medical SpecialtiesHealth Technology Biocartis SA develops molecular diagnostic solutions. It focuses on Oncology. The firm’s products include Idylla and Oncology assays and mutation tests. It also provides instant access to personalized medicine for patients. The company was founded by Rudi Pauwels in 2007 and is headquartered in Lausanne, Switzerland.
25
| Subsidiary | Medical Specialties | 25 |
| Public Company | Medical Specialties | 24 | |
18
| Public Company | Biotechnology | 18 |
Advent Venture Partners LLP
 Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom.
14
| Private Company | Investment Managers | 14 |
Smile Invest Management Co. NV
 Smile Invest Management Co. NV Investment ManagersFinance Smile Invest Management Co. NV (Smile Invest) is a private equity firm founded in 2017 by Urbain Vandeurzen. The firm is headquartered in Linden.
6
| Private Company | Investment Managers | 6 |
Galapagos Genomics NV
 Galapagos Genomics NV Pharmaceuticals: MajorHealth Technology Galapagos is a discovery company focused on the identification of disease modifying drug targets by functionally screening human disease models and the subsequent progression of these targets into drug discovery. Galapagos is a genomics based drug discovery company with programs in osteoporosis, rheumatoid arthritis, osteoarthritis, Alzheimer's disease and asthma.
3
| Extinct | Pharmaceuticals: Major | 3 |
Benaruca SA
3
| Subsidiary | Miscellaneous | 3 |
ANeuroTech
 ANeuroTech Miscellaneous Commercial ServicesCommercial Services ANeuroTech is a Belgian mental health company that specializes in developing innovative treatments with minimal or no side effects. ANeuroTech is located in Belgium. The private company's lead asset, ant-01, is an adjunctive anti-depression drug that has shown positive results in late-stage clinical trials. The drug is a low-dose of an existing substance, pipamperone dihydrochloride, and has an excellent safety profile. ANeuroTech plans to begin a pivotal phase iiib clinical trial of ant-01 as an adjunctive anti-depression drug for major depressive disorder (MDD) in 2023. The company was founded by CEO Dr. Erik Buntinx, an experienced clinician and key opinion leader in the field.
2
| Private Company | Miscellaneous Commercial Services | 2 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Rudi Pauwels via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| ASTRAZENECA PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
| AGILENT TECHNOLOGIES, INC. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
Charles River Discovery Research Services UK Ltd.
 Charles River Discovery Research Services UK Ltd. Miscellaneous Commercial ServicesCommercial Services Charles River Discovery Research Services UK Ltd. provides drug discovery products and services to various pharmaceutical companies. It focuses on three areas such as kinases, G-protein coupled receptors, and ion channels. The company was founded in 1997 and is headquartered in Kent, the United Kingdom. | Miscellaneous Commercial Services | Chief Executive Officer Corporate Officer/Principal Director/Board Member | |
| MDXHEALTH SA | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member Chairman | |
Ubiquisys Ltd.
 Ubiquisys Ltd. Computer CommunicationsElectronic Technology Ubiquisys Ltd. provides communication services. The company was founded on October 1, 2004 and is headquartered in Cardiff, the United Kingdom. | Computer Communications | Director/Board Member Director/Board Member | |
Artax Biopharma, Inc.
 Artax Biopharma, Inc. Medical SpecialtiesHealth Technology Artax Biopharma, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the development of new therapies for autoimmune and inflammatory diseases. The firm develops drugs targeting the interaction between T-cell Receptors (TCR) and Nck, a cytoplasmic adapter protein which plays a role in T-cell activation. The company was founded by Dami? Carulla Tormo in 2013 and is headquartered in Cambridge, MA. | Medical Specialties | Director/Board Member Chairman | |
| GIMV NV | Investment Managers | Director/Board Member Chairman Chief Executive Officer | |
| BEKAERT NV | Metal Fabrication | Director of Finance/CFO Director of Finance/CFO | |
Fujirebio Europe NV
 Fujirebio Europe NV Medical SpecialtiesHealth Technology Fujirebio Europe NV develops and markets diagnostic products to improve therapy management and patient health. It focuses on molecular diagnostics and multiparameter testing. The firm also provides LUMIPULSE G1200, an automated chemiluminescent enzyme immunoassay system; LUMIPULSE G600 II, an automated benchtop CLEIA system, routine and novel markers for the oncology sector. The company was founded in 1985 by Philippe Leboulch and is headquartered in Ghent, Belgium. | Medical Specialties | Director/Board Member Founder Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Participatiemaatschappij Vlaamse NV
 Participatiemaatschappij Vlaamse NV Investment ManagersFinance Participatiemaatschappij Vlaamse NV (VPM), also known as the Flemish Participation Company, is the investment arm of the Flemish Government based in Brussels, Belgium. Established in 2006, they focus on the management of the Flemish government's minority participation in the GIMV1 fund. GIMV-Gewestelijke Investerings Maatschappij Vlaanderen is a private equity firm founded in 1980 to provide capital to the Flemish industry, primarily in the ICT and life sciences sectors. | Investment Managers | Director/Board Member President | |
| University of Oxford | College/University | Corporate Officer/Principal Undergraduate Degree | |
| Maastricht University | College/University | Graduate Degree Undergraduate Degree Graduate Degree | |
KBC Securities NV
 KBC Securities NV Investment Banks/BrokersFinance KBC Securities NV is a broker/dealer firm headquartered in Brussels, Belgium. The firm was founded in 1998 and is a wholly owned subsidiary of KBC Bank NV, itself a subsidiary of KBC Groupe SA (EBR: KBC). KBC Securities provides liquidity and order execution services to institutional clients internationally, from investment banks to mutual funds and private investors. | Investment Banks/Brokers | Analyst-Equity Chairman | |
| University of Cambridge | College/University | Undergraduate Degree Graduate Degree | |
Participatiemaatschappij Vlaanderen NV
 Participatiemaatschappij Vlaanderen NV Investment ManagersFinance Participatiemaatschappij Vlaanderen NV (PMV) is a private equity/venture capital firm, a subsidiary of Region of Flanders founded in 1995. Participatiemaatschappij Vlaanderen NV is headquartered in Brussels, Belgium. | Investment Managers | Private Equity Investor Director/Board Member | |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | College/University | Graduate Degree Doctorate Degree | |
deVGen NV
 deVGen NV BiotechnologyHealth Technology deVGen NV provides biotechnology services for the pharmaceutical and agrochemical industries. It innovates in crop protection research and environment induced stress tolerance for its own crops and provides technology to corporate partners. The firm produces and sells its hybrid seeds in field crops such as rice, sunflower, sorghum and pearl millet in the Indian subcontinent and Southeast Asia. The company was founded by Thierry Bogaert on September 10, 1997 and is headquartered in Ghent, Belgium. | Biotechnology | Director/Board Member Director of Finance/CFO Director/Board Member | |
| ABLYNX | Biotechnology | Director/Board Member Director/Board Member Corporate Officer/Principal | |
Gimv (Private Equity)
 Gimv (Private Equity) Investment ManagersFinance Gimv (Private Equity) is a Private Equity firm, a subsidiary of Gimv NV (XB: GIMB) founded in 1980. Gimv (Private Equity) is headquartered in Antwerp, Belgium. | Investment Managers | Private Equity Investor Private Equity Investor | |
| University of Warwick | College/University | Corporate Officer/Principal Undergraduate Degree Doctorate Degree | |
| University of Leiden | College/University | Corporate Officer/Principal Doctorate Degree | |
| University of Groningen | College/University | Doctorate Degree Masters Business Admin | |
| Ghent University | College/University | Doctorate Degree Undergraduate Degree Graduate Degree Graduate Degree Graduate Degree Graduate Degree Doctorate Degree | |
| Swiss Federal Institute of Technology | College/University | Graduate Degree Masters Business Admin Corporate Officer/Principal | |
| University of Lausanne | College/University | Masters Business Admin Doctorate Degree | |
| Katholieke Universiteit Leuven | College/University | Graduate Degree Graduate Degree Graduate Degree Doctorate Degree Graduate Degree Graduate Degree Graduate Degree Doctorate Degree Graduate Degree Graduate Degree Graduate Degree Doctorate Degree | |
| Vrije Universiteit Brussel | College/University | Undergraduate Degree Graduate Degree | |
| Vlerick Leuven Gent Management School | College/University | General Counsel Masters Business Admin Masters Business Admin | |
MyCartis NV
 MyCartis NV BiotechnologyHealth Technology MyCartis NV develops technologies for healthcare personalization needs. It offers Evalution, a multiplex analysis platform to develop protein and nucleic-acid based clinical biomarkers. The company provides disruptive solutions in the fields of clinical and translational research for various applications in the detection of proteins and nucleic acids, such as sandwich immunoassays, antibody assays, genotyping assays, and mutation analysis assays to customers and partners. It offers products for various disease areas, including cell signalling, cardiovascular, oncology, and preeclampsia. The company was founded by Koen Kas in August 2004 and is headquartered in Ghent, Belgium. | Biotechnology | Director/Board Member Director/Board Member Chief Executive Officer Director/Board Member | |
Intrexon ActoBiotics NV
 Intrexon ActoBiotics NV BiotechnologyHealth Technology Intrexon ActoBiotics NV manufactures biopharmaceutical products. It focuses on the development and commercialization of a new generation of biological drugs. The company represents a novel concept for oral administration of therapeutic proteins, and is designed to be safer and more effective than injectable biopharmaceuticals. Intrexon Actobioticswas founded by Mark Vaeck, Emil Pot and Bernard Coulie in June 2006 and is headquartered in Zwijnaarde, Belgium. | Biotechnology | Director/Board Member Director/Board Member Chairman | |
Axonics Women's Health Ltd.
 Axonics Women's Health Ltd. Pharmaceuticals: MajorHealth Technology Contura Ltd. specializes in the distribution and sale of healthcare products, both in pharmaceuticals and medical devices. The firm focuses in the fields of urology and urogynaecology. Its products include bulkamid, cystistat, and aquamid. The company was founded by Henry Geoffrey McMillan in 2000 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Chairman Founder Director/Board Member | |
| Université Catholique de Louvain | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
FlandersBio vzw
 FlandersBio vzw Miscellaneous Commercial ServicesCommercial Services FlandersBio vzw is a life sciences cluster organization based in Flanders, Belgium. FlandersBio creates value by organizing networking and training activities, supporting internationalization, providing services, and building expertise. The Belgian company was founded by Jean Marie Stassen. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Chairman Director/Board Member | |
| Hogeschool-Universiteit Brussel | College/University | Graduate Degree Graduate Degree Undergraduate Degree | |
| University of Antwerp | College/University | Doctorate Degree Doctorate Degree Graduate Degree Graduate Degree Graduate Degree | |
Biocartis NV
 Biocartis NV Internet Software/ServicesTechnology Services Part of Biocartis Group NV, Biocartis NV is a Belgian molecular diagnostics company that aims to revolutionize the field with its proprietary IdyllaTM platform. The company is based in Mechelen, Belgium, and the CEO of the company is Herman Verrelst. The company provides next-generation diagnostic solutions with a focus on improving clinical practice in oncology for the benefit of patients, clinicians, payers, and the healthcare industry. | Internet Software/Services | Director/Board Member Director/Board Member Chairman Director/Board Member Director/Board Member Chief Executive Officer | |
miDIAGNOSTICS NV
 miDIAGNOSTICS NV Miscellaneous Commercial ServicesCommercial Services miDIAGNOSTICS NV develops a computer chip powered portable medical laboratory. The company is headquartered in Leuven, Belgium. | Miscellaneous Commercial Services | Director/Board Member Chairman Director/Board Member | |
Antelope Dx BV
 Antelope Dx BV Packaged SoftwareTechnology Services Antelope Dx BV develops a point-of-need diagnostics platform that provides patients, consumers, and healthcare professionals with on-the-spot access to key health parameters. The private company is based in Ghent, Belgium. The Belgian company was founded in 2019 by Jan-Willem Hoste and Hilde Windels. Hilde Windels has been the CEO since 2019. | Packaged Software | Director/Board Member Founder | |
Cergentis BV
 Cergentis BV Miscellaneous Commercial ServicesCommercial Services Part of Solvias AG, Cergentis BV is a Dutch genomics company that develops and commercializes TLA-based diagnostic kits for targeted complete next-generation sequencing of (trans) genes and gene editing events. The company is based in Utrecht, Netherlands. The company also provides commercial services for leading research institutes and pharmaceutical companies worldwide. The company was founded in 2012. Joris Schuurmans has been the CEO of the company since 2020. Cergentis was acquired by Solvias AG on July 12, 2022. | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer | |
Leyden Laboratories B.V.
 Leyden Laboratories B.V. Miscellaneous Commercial ServicesCommercial Services Leyden Laboratories B.V. is a biotechnology company based in Amsterdam, Netherlands. Leyden Labs aims to protect humanity from known and future viruses by targeting commonalities of viral families. The Dutch company has developed a portfolio of accessible intranasal product candidates that may provide people with the freedom to immediately protect themselves from and prevent the spread of many strains of respiratory viruses, including ones in the influenza and coronavirus families. The company's energetic team of world-renowned biotechnology veterans and fresh talent is dedicated to thinking differently to free humanity from the burden of respiratory viruses. Leyden Labs is backed with $200m by blue-chip investors Casdin Capital, GV (formerly Google Ventures), F-Prime Capital, Byers Capital/Brook Byers, SoftBank Investment Advisers, Invus, and Bluebird Ventures. The company was founded in June 2020 by Koenraad Wiedhaup, Jaap Goudsmit, Domenico Valerio, and Ronald H. P. Brus, with Koenraad Wiedhaup serving as the CEO since incorporation. | Miscellaneous Commercial Services | Founder Founder Director/Board Member | |
Mf Hold BV
 Mf Hold BV Financial ConglomeratesFinance MF Hold BV is an investment holding Belgian company founded in 2019. The private company is based in Lochristi, Belgium. The company's main function is to hold investments. | Financial Conglomerates | Director/Board Member Director/Board Member | |
| CELLNOVO | Medical Specialties | Corporate Officer/Principal Director/Board Member |
Statistiques
Internationale
| Belgique | 31 |
| Royaume-Uni | 8 |
| Pays-Bas | 8 |
| Etats-Unis | 4 |
| Allemagne | 2 |
Sectorielle
| Health Technology | 17 |
| Consumer Services | 17 |
| Commercial Services | 8 |
| Finance | 8 |
| Technology Services | 3 |
Opérationnelle
| Director/Board Member | 395 |
| Corporate Officer/Principal | 129 |
| Chairman | 79 |
| Chief Executive Officer | 64 |
| Independent Dir/Board Member | 62 |
Relations les plus connectées
| Insiders | |
|---|---|
| Raj Bhikhu Parekh | 50 |
| Ann-Christine Sundell | 33 |
| Rudi Mariën | 31 |
| Ferdinand Verdonck | 25 |
| Roald Borré | 25 |
| Dirk Boogmans | 22 |
| Dale Pfost | 22 |
| Staf van Reet | 22 |
| David Smith | 21 |
| Urbain Vandeurzen | 20 |
| Luc Gijsens | 20 |
| Harrold van Barlingen | 20 |
| Graham Dixon | 18 |
| Hilde Windels | 18 |
| Ruth Devenyns | 18 |
- Bourse
- Insiders
- Rudi Pauwels
- Connexions Sociétés
